Diabetes, Vol 37, Issue 10 1358-1364, Copyright © 1988 by American Diabetes Association

ARTICLES

Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats

B Rodrigues, H Xiang and JH McNeill
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.

The beneficial effects of L-carnitine administration were studied in vivo in isolated perfused working hearts from control and diabetic rats. Control and streptozocin-induced diabetic (STZ-D) rats were treated daily for 6 wk with high-dose L-carnitine (3 g.kg-1.day-1 i.p.). STZ-D results in loss of body weight and hypoinsulinemia. These effects were not altered by L-carnitine treatment. Myocardial free-carnitine levels were decreased in the untreated diabetic rats. L-Carnitine treatment of the diabetic rats increased myocardial free-carnitine levels, which were comparable with those of control rats. Six weeks after STZ administration, hearts from untreated diabetic animals exhibited depressed left ventricular developed pressure, cardiac contractility, and ventricular relaxation rates compared with control animals. However, this depression was not seen in the L-carnitine-treated diabetic animals. L-Carnitine treatment of diabetic rats significantly reduced plasma glucose and lipid levels but had no effect on control rats. Furthermore, thyroid hormone levels were higher in the L-carnitine-treated diabetic rats than in the untreated diabetic group. The data suggest that high-dose L-carnitine treatment may reduce the severity of diabetes and result in improved cardiac performance.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. N. Finck, X. Han, M. Courtois, F. Aimond, J. M. Nerbonne, A. Kovacs, R. W. Gross, and D. P. Kelly A critical role for PPARalpha -mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content PNAS, February 4, 2003; 100(3): 1226 - 1231. [Abstract] [Full Text] [PDF]

				T. L. Broderick, W. R. Driedzic, M. Gillis, J. Jacob, and T. Belke Effects of Chronic Food Restriction and Exercise Training on the Recovery of Cardiac Function Following Ischemia J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 33B - 37. [Abstract] [Full Text]

				A. D. Gaetano, G. Mingrone, M. Castagneto, and M. Calvani Carnitine Increases Glucose Disposal in Humans J. Am. Coll. Nutr., August 1, 1999; 18(4): 289 - 295. [Abstract] [Full Text] [PDF]

				J. Nakamura, N. Koh, F. Sakakibara, Y. Hamada, T. Hara, H. Sasaki, S. Chaya, T. Komori, E. Nakashima, K. Naruse, et al. Polyol Pathway Hyperactivity Is Closely Related to Carnitine Deficiency in the Pathogenesis of Diabetic Neuropathy of Streptozotocin-Diabetic Rats J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 897 - 902. [Abstract] [Full Text]

				G. Shepherd, M. C. Cam, N. Sambandam, M. A. Abrahani, and B. Rodrigues Streptozotocin-Induced Diabetes Enhances Cardiac Heparin-Releasable Lipoprotein Lipase Activity in Spontaneously Hypertensive Rats Hypertension, March 1, 1998; 31(3): 878 - 884. [Abstract] [Full Text] [PDF]

				A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, G. Bronns, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats J. Physiol., January 9, 2002; 538(2): 541 - 553. [Abstract] [Full Text] [PDF]

				A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition J. Physiol., January 9, 2002; 538(2): 555 - 572. [Abstract] [Full Text] [PDF]